← 返回前沿论文

工程化间充质干细胞-NK 细胞复合物用于空间靶向与功能重焕的肿瘤免疫治疗

英文原题:Engineered Mesenchymal Stem Cell-NK Cell Complexes for Spatially Targeted and Functionally Revitalized Cancer Immunotherapy.

PubMed 2025/08/19(内容时间) Adv Sci (Weinh) Q1 · IF 14.1(JCR 2025)

研究概要

综合来看,工程化的 SC 辅助递送系统有望克服 NK 细胞疗法的局限,并改善其在实体瘤中的治疗结局。

中文摘要

自然杀伤(NK)细胞具有内在细胞毒性,且可不依赖抗原呈递靶向肿瘤细胞,因此是一种有力的免疫治疗策略。然而,其对实体瘤的临床疗效受肿瘤浸润不足及免疫抑制性微环境中的功能受损所限。本研究开发了一种基因工程化细胞-细胞复合递送系统:将 NK 细胞与表达 IL-15 的脂肪来源间充质细胞(SC)结合。研究利用 SC 固有的肿瘤趋向性,并通过脂质纳米颗粒介导的 mRNA 转染使其持续表达 IL-15;由此形成的 SC-NK 细胞复合物显著改善肿瘤定位,并持续增强细胞因子介导的功能。通过生物正交点击化学实现精准连接后,该策略在原位小鼠肺癌及患者来源异种移植卵巢癌模型中有效提高 NK 细胞浸润并恢复其细胞毒活性。研究还发现,该细胞复合物对半乳糖凝集素-9阻断治疗的应答增强,可逆转 NK 细胞功能障碍并显著提高抗肿瘤疗效。总体而言,这种由工程化 SC 辅助的递送系统有望克服 NK 细胞疗法的局限,改善实体瘤治疗效果。

展开英文摘要原文

Natural killer (NK) cells represent a powerful immunotherapeutic strategy due to their intrinsic cytotoxicity and ability to target tumor cells independently of antigen presentation. However, their clinical efficacy against solid tumors is limited by poor tumor infiltration and impaired functionality within the immunosuppressive microenvironment. Here, a genetically engineered cell-cell complex delivery system comprising NK cells conjugated to IL-15 expressing adipose-derived mesenchymal stem cells (SCs) is developed. By exploiting SCs' intrinsic tumor-tropic properties and engineering them to consistently express interleukin-15 (IL-15) via lipid nanoparticle-mediated mRNA transfection, the SC-NK cell complexes exhibit markedly improved tumor localization and sustained cytokine-mediated functional enhancement. Utilizing bioorthogonal click chemistry for precise conjugation, the approach effectively enhances NK cell infiltration and revitalizes their cytotoxic activity in both orthotopic murine lung cancer and patient-derived xenograft ovarian cancer models. Furthermore, increased responsiveness of the cell-cell complexes to Galectin-9 blockade therapy is identified, leading to the reversal of NK cell dysfunction and significantly augmented antitumor efficacy. Collectively, the engineered SC-assisted delivery system holds potential for overcoming the limitations of NK cell therapies and improving their therapeutic outcomes in solid tumor.

论文信息

作者
Zhang Q、Yin B、Sabier M、Yang Y、Wu M、Zhao Z、Luo X、Zhong Y
单位
Department of Geriatric Respiratory and Critical Care, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.China
期刊
Advanced science (Weinheim, Baden-Wurttemberg, Germany)2026 Jun
原文标识
PubMed 40827682 · DOI 10.1002/advs.202509638